Concepedia
Statistics
Publications
50
Citations
2.7K
H-Index
29
Active since
1994
Affiliations
Dana-Farber Cancer Institute(Current)
Brigham and Women's Hospital
Dana-Farber Brigham Cancer Center
Harvard University
Beth Israel Deaconess Medical Center
Laura A. Goguen is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and radiation oncology.
Publications per year
1994–2024
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
Jonathan D. Schoenfeld, Glenn J. Hanna, Vickie Y. Jo et al. · JAMA Oncology · 2020 · 347 citations · Full text
Medicine, Immunology, Oncology +17
Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy
Hale Başak Çağlar, Roy B. Tishler, Megan Othus et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 230 citations
Medicine, Otolaryngology, Radiation Oncology +14
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B. Afeyan et al. · Science Immunology · 2023 · 116 citations · Full text
Dysphagia after Sequential Chemoradiation Therapy for Advanced Head and Neck Cancer
Laura A. Goguen, Marshall R. Posner, Charles M. Norris et al. · Otolaryngology · 2006 · 105 citations
Medicine, Oncology, Radiation Oncology +17
Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
Glenn J. Hanna, Anne O’Neill, Kee‐Young Shin et al. · Clinical Cancer Research · 2021 · 103 citations · Full text
1–5 of 50